An investigation on behalf of investors in CEL-SCI Corporation (NYSE: CVM) shares over potential wrongdoing at CEL-SCI Corporation was announced.
San Diego, CA -- (SBWIRE) -- 04/18/2019 -- An investigation was announced for investors in shares of CEL-SCI Corporation (NYSE: CVM) over potential breaches of fiduciary duties by certain directors at CEL-SCI Corporation.
Investors who purchased shares of CEL-SCI Corporation (NYSE: CVM) and currently hold any of those NYSE: CVM shares have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain CEL-SCI Corporation directors breached their fiduciary duties and caused damage to the company and its shareholders.
Vienna, VA based CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and other diseases. CEL-SCI Corporation reported its Net Loss increased from $14.36 million for the 12 months period that ended on September 30, 2017 to $31.83 million for the 12 months period that ended on September 30, 2018.
Shares of CEL-SCI Corporation (NYSE: CVM) closed on April 12, 2019, at $5.77 per share.
Those who purchased shares of CEL-SCI Corporation (NYSE: CVM), have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels